Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC

Advances in Therapy

Volumn 25, Issue 8, 2008, Pages 787-794

  Yang, Po ^a   Liang, Minghui ^b   Zhang, Yingxun ^a   Shen, Baozhong ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b QIQIHAR MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Lentinan; Radiofrequency ablation; Transcatheter hepatic arterial chemoembolisation

Indexed keywords

ANTINEOPLASTIC AGENT; LENTINAN;

ADULT; AGED; ARTICLE; CATHETER ABLATION; CHEMOEMBOLIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LENTINAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL RATE;

EID: 58749105130     PISSN: 0741238X     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-008-0079-x     Document Type: Article

References (19)

1. Höpfner M, Huether A, Sutter A, Baradari V, Schuppan D, Scherübl H. Blockade of IGF-1 receptor tyrosine kinase has antineoplastic Effects in hepatocellular carcinoma cells. Biochem Pharmacol. 2006;71:1435-1448.
2. Cormier JN, Tomas KT, Chari RS, Pinson CW. Management of hepatocellular carcinoma. J Gastrointest Surg. 2006;10:761-780. (Pubitemid 43711147)
3. Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut. 2003;52:1-8.
4. McEntee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery. 1990;108:1091-1096.
5. Lee CM, Lu SN, Changchien CS, et al. Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection. Cancer. 1999;86:1143-1150.
6. Moertel CG, Johnson CM, McKusick MA, et al. The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med. 1994;120:302-309. (Pubitemid 24050027)
7. Baere T, Dufaux J, Roche A, et al. Circulatory alterations induced by intra-arterial injection of iodized oil and emulsions of iodized oil and doxorubicin: experimental study. Radiology. 1995;194:165-170. (Pubitemid 24380945)
8. De Mitri MS, Puossin K, Baccarini P, et al. HCV-associated liver cancer without cirrhosis. Lancet. 1995;345:413-415.
9. Liapi E, Geschwind JFH. Transcatheter arterial chemoembolisation (TACE) for HCC-classic concepts and future evolution. Eur Oncological Dis. 2006;1:47-52.
10. Tsukuma H, Hiyami T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993;328:1797-1801. (Pubitemid 23174709)
11. Frazer C. Imaging of hepatocellular carcinoma. J Gastroenterol Hepatol. 1999;14:750-756. (Pubitemid 29426407)
12. Sugimori K, Nozawa A, Morimoto M, et al. Extension of radiofrequency ablation of the liver by transcatheter arterial embolization with iodized oil and gelatin sponge: results in a pig model. J Vasc Interv Radiol. 2005;16:849-856. (Pubitemid 40847906)
13. Dominguez S, Denys A, Madeira I, et al. Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumors. Eur J Gastroenterol Hepatol. 2000;12:151-157. (Pubitemid 30166679)
14. Casadei R, Tomassetti P, Rossi C, la Donna M, Migliori M, Marrano D. Treatment of metastatic glucagonoma to the liver: case report and literature review. Ital J Gastroenterol Hepatol. 1999;31:308-312. (Pubitemid 29312737)
15. Bizollon T, Rode A, Bancel B, et al. Diagnostic value and tolerance of lipiodol-computed tomography for the detection of small hepatocellular carcinoma: correlation with pathologic examination of explanted livers. J Hepatol. 1998;28:491-496. (Pubitemid 28133554)
16. Wu P, Zhang F, Zhao M, et al. Combination of transcatheter arterial chemoembolization and CT-guided radiofrequency ablation in treating advanced hepatocellular carcinoma. Chin J Radiology (Chin). 2003;37:901-904.
17. Zhang L, Cui Z, Zhao Q, et al. RFA combined with TACE and ethanol injection for unresectable hepatic carcinoma. Chin J General Surg (Chin). 2002;40:826-829.
18. Lindequist U, Niedermeyer TH, Jülich WD. The pharmacological potential of mushrooms. eCAM. 2005;2:285-299. (Pubitemid 41258148)
19. Wasser SP, Weis AL. Medicinal properties of substances occurring in higher basidiomycetes mushrooms: current perspectives (review). Int J Med Mushrooms. 1999;1:31-62.